Results of a clinical trial show that giving chemotherapy along with hormone therapy can prolong the lives of men with a certain type of metastatic prostate cancer.

  • Giving chemotherapy along with hormone therapy can prolong the lives of men with a certain type of metastatic prostate cancer.
  • The trial results could change how metastatic prostate cancer is treated.

Prostate cancer is the second most common cancer in men in the United States, after skin cancer. The prostate is a gland that lies just below the bladder in front of the rectum. It surrounds the urethra (the tube that carries urine and semen through the penis and out of the body) and makes fluid that forms part of semen.

Man talking to doctor.

An experimental treatment strategy may prolong life for men who have a certain type of metastatic prostate cancer.

Prostate cancer often has no early symptoms and usually grows very slowly. More than half of prostate cancers remain localized to the prostate and don’t become life-threatening. They can be treated with surgery or radiation, and in some cases don’t need treatment.

For more information visit: nih.gov

Advertisements